CPhI Worldwide announces the finalists for the CPhI Pharma Awards
The winners of the 16th CPhI Pharma Awards will be announced on the evening of the first day at CPhI Worldwide
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA approves AstraZeneca’s diabetes drug for treating heart failure risk
The approval by the US Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial
Granules gets US FDA nod for allergy treatment drug
The approved product is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of…
Lupin’s Nagpur facility receives EIR from the US FDA
The inspection for the oral solid facility at Nagpur closed without any Form 483 observation
Cipla acquires anti-infective product Elores from Venus Remedies
The acquisition is aimed at further strengthening the firm's presence in branded Indian critical care space, and as a part of its…
Indoco’s Clinical Research Organisation receives zero 483s from US FDA
The company also recently successfully concluded an audit by US FDA at its sterile manufacturing facility in Goa (Plant II)
Teva’s UK arm recalls some batches of Ranitidine: Medicines watchdog
Teva, the world's largest generic drugmaker, is recalling all unexpired stock of Ranitidine Effervescent Tablets in 150 micrograms…
Second edition of US-India IP Dialogue held in Delhi
The “IP Dialogue: Opportunities for U.S.-India Collaboration,” an initiative on IP-led innovation, brought together experts from…
Teva to donate over $15 bln worth of drugs in opioid settlement: Source
Teva has offered to give away generic drugs, including those that help fight opioid overdose, to resolve all of its cases in an…
Roche boosts 2019 sales outlook, sees Spark deal this year
Sales in the third quarter rose 13 per cent to 15.6 billion Swiss francs ($15.64 billion), the Basel-based drugmaker said, citing…